◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

NervGen Pharma Corp.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 1.7M 3.8M 2.9M 2.2M 2.8M
General And Administrative Expense 1.7M 3.8M 2.9M 2.2M 2.8M
Research And Development 4.4M 2.7M 3.1M 4.6M 4.4M
Depreciation And Amortization In Income Statement 0.00 0.00 0.00 1,863 703.00
Operating Expense 6.2M 6.5M 6.0M 6.8M 7.2M
Operating Income -6.2M -6.5M -6.0M -6.8M -7.2M
EBIT -6.2M -6.5M -6.0M -6.8M -7.2M
Interest Income 77,071 86,904 107,761 171,110 243,679
Interest Income Non Operating 77,071 86,904 107,761 171,110 243,679
Net Interest Income 77,071 86,904 107,761 171,110 243,679
Other Income Expense 1.9M -2.7M 2.0M -2.0M 1.7M
Gain On Sale Of Security 1.9M -2.7M 2.0M -2.0M 1.7M
Pretax Income -4.2M -9.1M -3.9M -8.6M -5.3M
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -4.2M -9.1M -3.9M -8.6M -5.3M
Net Income From Continuing Operation Net Minority Interest -4.2M -9.1M -3.9M -8.6M -5.3M
Net Income Including Noncontrolling Interests -4.2M -9.1M -3.9M -8.6M -5.3M
Net Income Common Stockholders -4.2M -9.1M -3.9M -8.6M -5.3M
Net Income -4.2M -9.1M -3.9M -8.6M -5.3M
EBITDA -6.2M -6.5M -6.0M -6.8M -7.2M
Normalized EBITDA -8.1M -3.7M -8.0M -4.8M -8.9M
Reconciled Depreciation 13,949 13,948 13,949 15,811 14,652
Basic EPS -0.06 -0.13 -0.06 -- -0.08
Diluted EPS -0.06 -0.13 -0.06 -- -0.08
Basic Average Shares 73.2M 72.0M 70.7M -- 70.1M
Diluted Average Shares 73.2M 72.0M 70.7M -- 70.1M
Total Unusual Items 1.9M -2.7M 2.0M -2.0M 1.7M
Total Unusual Items Excluding Goodwill 1.9M -2.7M 2.0M -2.0M 1.7M
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -6.1M -6.4M -5.9M -6.6M -7.0M
Depreciation Amortization Depletion Income Statement 0.00 0.00 0.00 1,863 703.00
Depreciation Income Statement 0.00 0.00 0.00 1,863 703.00
Diluted NI Availto Com Stockholders -4.2M -9.1M -3.9M -8.6M -5.3M
Net Income Continuous Operations -4.2M -9.1M -3.9M -8.6M -5.3M
Net Non Operating Interest Income Expense 77,071 86,904 107,761 171,110 243,679
Other Gand A 627,861 1.1M 999,989 542,501 925,149
Salaries And Wages 1.1M 2.7M 1.9M 1.7M 1.9M
Total Expenses 6.2M 6.5M 6.0M 6.8M 7.2M
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 11.4M 15.7M 14.5M 17.3M 21.0M
Cash Cash Equivalents And Short Term Investments 11.4M 15.7M 14.6M 17.4M 21.0M
Other Short Term Investments 33,225 57,713 81,838 97,234 --
Accounts Receivable -- -- -- -- 6,437
Receivables 344,205 96,954 333,766 415,301 102,227
Prepaid Assets 601,686 364,155 433,263 716,951 834,073
Other Current Assets 22,528 45,056 67,584 105,664 --
Current Assets 12.7M 16.5M 15.4M 19.0M 21.9M
Gross PPE -- -- -- 0.00 1,863
Net PPE -- -- -- 0.00 1,863
Goodwill And Other Intangible Assets 423,112 437,061 451,009 464,958 478,906
Other Intangible Assets 423,112 437,061 451,009 464,958 478,906
Investments And Advances 0.00 0.00 0.00 8,369 --
Other Investments 0.00 0.00 0.00 8,369 --
Total Non Current Assets 423,112 437,061 451,009 473,327 513,995
Total Assets 13.1M 16.9M 15.8M 19.5M 22.5M
Current Debt And Capital Lease Obligation 33,225 57,713 81,838 97,234 95,790
Accounts Payable -- -- -- -- 457,289
Payables 38,800 39,167 38,588 33,439 1.0M
Payables And Accrued Expenses 4.4M 4.2M 3.9M 3.8M 3.4M
Current Accrued Expenses 4.3M 4.1M 3.8M 3.7M 2.4M
Other Current Liabilities 10.6M 12.6M 9.9M 11.9M 9.8M
Current Liabilities 16.0M 17.8M 14.4M 16.9M 13.2M
Long Term Debt And Capital Lease Obligation 0.00 0.00 0.00 8,369 33,226
Long Term Capital Lease Obligation 0.00 0.00 0.00 8,369 33,226
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 8,369 33,226
Total Liabilities Net Minority Interest 16.0M 17.8M 14.4M 16.9M 13.3M
Common Stock 90.5M 88.4M 82.4M 81.1M 80.5M
Capital Stock 90.5M 88.4M 82.4M 81.1M 80.5M
Retained Earnings -119.9M -115.2M -106.1M -102.2M -93.6M
Gains Losses Not Affecting Retained Earnings 26.4M 25.9M 25.1M 23.6M 22.2M
Common Stock Equity -2.9M -918,421 1.4M 2.6M 9.2M
Stockholders Equity -2.9M -918,421 1.4M 2.6M 9.2M
Total Equity Gross Minority Interest -2.9M -918,421 1.4M 2.6M 9.2M
Total Capitalization -2.9M -918,421 1.4M 2.6M 9.2M
Net Tangible Assets -3.4M -1.4M 938,468 2.1M 8.7M
Tangible Book Value -3.4M -1.4M 938,468 2.1M 8.7M
Working Capital -3.4M -1.4M 938,468 2.1M 8.7M
Invested Capital -2.9M -918,421 1.4M 2.6M 9.2M
Total Debt 33,225 57,713 81,838 105,603 129,016
Share Issued 73.4M 72.8M 70.9M 70.3M 70.2M
Ordinary Shares Number 73.4M 72.8M 70.9M 70.3M 70.2M
Capital Lease Obligations 33,225 57,713 81,838 105,603 129,016
Current Capital Lease Obligation 33,225 57,713 81,838 97,234 95,790
Current Deferred Assets 288,641 248,073 0.00 410,257 --
Dueto Related Parties Current -- -- -- -- 578,830
Non Current Accounts Receivable -- -- -- -- 33,226
Other Payable 38,800 39,167 38,588 33,439 --
Other Properties -- -- -- -- 1,863
Other Receivables 287,144 25,315 202,922 270,645 95,790
Pensionand Other Post Retirement Benefit Plans Current 1.0M 1.1M 636,246 1.2M --
Taxes Receivable 57,061 71,639 130,844 144,656 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -5.3M -3.7M -4.1M -3.7M -5.8M
Cash Flow From Continuing Operating Activities -5.3M -3.7M -4.1M -3.7M -5.8M
Depreciation And Amortization 13,949 13,948 13,949 15,811 14,652
Depreciation Amortization Depletion 13,949 13,948 13,949 15,811 14,652
Stock Based Compensation 1.1M 2.0M 1.5M 1.7M 1.9M
Change In Working Capital -298,913 793,527 355,545 743,292 -495,149
Changes In Account Receivables -- 236,812 81,535 -408,864 5,112
Change In Receivables -247,251 236,812 81,535 -408,864 5,112
Change In Payables And Accrued Expense 203,907 713,154 -458,015 1.2M -335,343
Change In Payable -- -- -- -- -335,343
Other Non Cash Items -- -- -- -1.00 1.00
Purchase Of PPE -- -- -- 0.00 0.00
Net PPE Purchase And Sale -- -- -- 0.00 -8,411
Investing Cash Flow 25,232 25,231 25,232 25,232 25,231
Cash Flow From Continuing Investing Activities 25,232 25,231 25,232 25,232 25,231
Repayment Of Debt -25,232 -25,231 -25,232 -25,231 -25,232
Net Issuance Payments Of Debt -25,232 -25,231 -25,232 -25,231 -25,232
Issuance Of Capital Stock 1.00 1.1M 1.6M 0.00 0.00
Net Common Stock Issuance 1.00 1.1M 1.6M 0.00 0.00
Financing Cash Flow 995,203 4.8M 1.3M 310,000 269,737
Cash Flow From Continuing Financing Activities 995,203 4.8M 1.3M 310,000 269,737
Effect Of Exchange Rate Changes -12,954 90,659 22,884 -416,189 -93,555
Changes In Cash -4.3M 1.1M -2.8M -3.3M -5.5M
Beginning Cash Position 15.7M 14.5M 17.3M 21.0M 26.6M
End Cash Position 11.4M 15.7M 14.5M 17.3M 21.0M
Free Cash Flow -5.3M -3.7M -4.1M -3.7M -5.8M
Interest Paid Supplemental Data 0.00 0.00 0.00 0.00 0.00
Amortization Cash Flow 13,949 13,948 13,949 13,948 13,949
Amortization Of Intangibles 13,949 13,948 13,949 13,948 13,949
Change In Account Payable -- -- -- -- -335,343
Change In Prepaid Assets -255,569 -156,439 732,025 -9,733 -164,918
Common Stock Issuance 1.00 1.1M 1.6M 0.00 0.00
Depreciation 0.00 0.00 0.00 1,863 703.00
Gain Loss On Investment Securities -2.0M 2.7M -2.0M 2.1M -1.8M
Gain Loss On Sale Of PPE 0.00 -- -- 0.00 0.00
Long Term Debt Payments -25,232 -25,231 -25,232 -25,231 -25,232
Net Foreign Currency Exchange Gain Loss -5,912 -83,826 -5,040 414,811 93,555
Net Income From Continuing Operations -4.2M -9.1M -3.9M -8.6M -5.5M
Net Intangibles Purchase And Sale -- -- 25,232 25,232 25,231
Net Long Term Debt Issuance -25,232 -25,231 -25,232 -25,231 -25,232
Net Other Financing Charges -80,575 -144,616 -460,153 0.00 19.00
Operating Gains Losses -2.0M 2.6M -2.0M 2.5M -1.7M
Proceeds From Stock Option Exercised 1.1M 3.8M 120,000 335,231 294,950
Purchase Of Intangibles -- -- -- 0.00 --
Sale Of Intangibles -- -- 25,232 25,232 25,231
Sale Of PPE -- -- -- 0.00 -8,411
NEWS
Loading news...
TRENDING
Loading...